A patient in New York has been infected with a strain of E. coli highly resistant to last-resort antibiotic treatments, according to an article on the Becker's Infection Control and Clinical Quality website.
This is the second U.S. patient with the untreatable superbug infection, following a Pennsylvania patient first made public last month.
The mcr-1 gene gives bacteria resistance to colistin, a last-line-of-defense antibiotic used to combat a number of resistant microorganisms.
Going into 2017, the White House has requested $1.1 billion be allocated to efforts to combat antibiotic resistance in the U.S.
Parking: Where the Outpatient Land Crunch Shows First
Clear Behavioral Health Opens New Outpatient Mental Health Center in Anaheim Hills
Bon Secours Begins Construction on Freestanding Emergency Department in Norfolk
The OR HVAC Puzzle: Why Individual Systems Are on the Rise
Skanska Completes Renovation of Specialized Care Facility for Sutter Health